Ascend Capital’s Xylem XYL Stock Holding History

Ascend Capital’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-300,525	Closed	-$20.2M	–	224
2018 Q2	$20.2M	Buy	300,525 +223,635	+291%	+$16.2M	0.95%	35
2018 Q1	$5.91M	Sell	76,890 -663,658	-90%	-$49.1M	0.24%	114
2017 Q4	$50.5M	Buy	740,548 +13,896	+2%	+$923K	1.9%	8
2017 Q3	$45.5M	Buy	726,652 +490,540	+208%	+$29.3M	1.72%	12
2017 Q2	$13.1M	Buy	236,112 +226,658	+2,397%	+$11.8M	0.61%	59
2017 Q1	$474K	Buy	+9,454	New	+$461K	0.02%	138

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ascend Capital's XYL Position: Q3 2018 in Review

Ascend Capital sold out of Xylem (XYL) in Q3 2018, closing a stake of 300,525 shares — an estimated $20.2M sold.

Ascend Capital first reported a position in XYL in Q1 2017 and held it in 6 quarters. The position peaked at $50.5M in Q4 2017. 666 funds tracked by Wall St. Rank hold XYL as of Q3 2018.

Ascend Capital reported no remaining Xylem position as of Q3 2018 after selling out during the quarter.
Ascend Capital sold 300,525 Xylem shares in Q3 2018, an estimated $20.2M.
Ascend Capital first reported a position in Xylem in Q1 2017 and held it in 6 quarters.
Ascend Capital's Xylem position peaked at $50.5M in Q4 2017.
666 funds tracked by Wall St. Rank held Xylem as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.